Pietro Del Medico

Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

Gabriella Ferrandina, M. Ludovisi, Domenica Lorusso et al. · Journal of Clinical Oncology · 2008 · 295 citations · Full text

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

Sandro Pignata, Giovanni Scambia, Gabriella Ferrandina et al. · Journal of Clinical Oncology · 2011 · 212 citations · Full text

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Giulia Bon, Laura Pizzuti, Valentina Laquintana et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 72 citations · Full text

Early blood rise in auto‑antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic‑non‑small cell lung cancer patients treated with PD‑1 immune‑check point blockade by nivolumab

Rocco Giannicola, Graziella D’Arrigo, Cirino Botta et al. · Molecular and Clinical Oncology · 2019 · 52 citations · Full text

Mnsclc Patients, Immunology, Immunoediting +19

One-stage, totally laparoscopic major hepatectomy and colectomy for colorectal neoplasm with synchronous liver metastasis: Safety, feasibility and short-term outcome

Marcello Spampinato, Lucio Mandalà, Giuseppe Quarta et al. · Surgery · 2012 · 43 citations

Surgical Oncology, Hepatology, Colorectal Surgery +10